Hydroxyapatite-dextran methacrylate core/shell hybrid nanocarriers for combinatorial drug therapy

In this study, a hybrid dual drug-loaded hydroxyapatite-oxidized dextran methacrylate core–shell nanocarrier was formulated and explored for combinatorial delivery of doxorubicin (DOX) and methotrexate (MTX) to bone cancer. The synthesized nanocarrier was well characterized by different techniques....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of materials research 2020-09, Vol.35 (18), p.2451-2465
Hauptverfasser:	Ram Prasad, S., Jayakrishnan, A., Sampath Kumar, T. S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adsorption Apoptosis Applied and Technical Physics Biocompatibility Biomaterials Biomedical materials Biomedical Materials, Regenerative Medicine and Drug Delivery Bone cancer Cancer Cancer therapies Chemotherapy Combination therapy Combinatorial analysis Dextrans Doxorubicin Drug delivery systems Drug dosages Efficiency Ewings sarcoma Gene expression Hydroxyapatite Inorganic Chemistry Materials Engineering Materials research Materials Science Methotrexate Nanoparticles Nanotechnology Oxidation Polymers Radiation therapy Sequential delivery Toxicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!